Diamond Hill Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$132M Sell
1,684,110
-299,750
-15% -$24.2M 1.05% 32
2026
Q1
$172M Sell
1,983,860
-323,726
-14% -$31M 1.08% 33
2025
Q4
$222M Sell
2,307,586
-423,819
-16% -$41.2M 1.14% 35
2025
Q3
$260M Sell
2,731,405
-203,087
-7% -$18.7M 1.24% 33
2025
Q2
$256M Sell
2,934,492
-148,508
-5% -$12.6M 1.18% 38
2025
Q1
$277M Sell
3,083,000
-1,108,837
-26% -$99.2M 1.27% 34
2024
Q4
$335M Buy
4,191,837
+525,877
+14% +$45.5M 1.48% 26
2024
Q3
$330M Sell
3,665,960
-23,340
-0.6% -$1.96M 1.34% 36
2024
Q2
$290M Sell
3,689,300
-259,059
-7% -$21.2M 1.24% 37
2024
Q1
$344M Buy
3,948,359
+48,080
+1% +$4.1M 1.4% 28
2023
Q4
$321M Buy
3,900,279
+177,692
+5% +$13.5M 1.41% 29
2023
Q3
$292M Buy
3,722,587
+161,357
+5% +$13.5M 1.41% 28
2023
Q2
$314M Sell
3,561,230
-10,794
-0.3% -$929K 1.41% 28
2023
Q1
$288M Buy
3,572,024
+31,230
+0.9% +$2.55M 1.35% 28
2022
Q4
$275M Sell
3,540,794
-134,828
-4% -$10.9M 1.25% 33
2022
Q3
$297M Buy
3,675,622
+15,640
+0.4% +$1.41M 1.42% 27
2022
Q2
$328M Sell
3,659,982
-450,789
-11% -$45.7M 1.44% 26
2022
Q1
$456M Buy
4,110,771
+53,052
+1% +$5.6M 1.7% 18
2021
Q4
$420M Sell
4,057,719
-534,888
-12% -$61.9M 1.5% 25
2021
Q3
$576M Sell
4,592,607
-8,245
-0.2% -$1.07M 2.18% 8
2021
Q2
$571M Buy
4,600,852
+259,981
+6% +$32.6M 2.17% 10
2021
Q1
$513M Buy
4,340,871
+514,206
+13% +$60.3M 2.07% 9
2020
Q4
$448M Buy
3,826,665
+170,386
+5% +$18.8M 2.11% 9
2020
Q3
$380M Sell
3,656,279
-16,019
-0.4% -$1.61M 2.1% 12
2020
Q2
$337M Buy
3,672,298
+27,130
+0.7% +$2.6M 1.99% 12
2020
Q1
$329M Sell
3,645,168
-12,350
-0.3% -$1.31M 2.23% 7
2019
Q4
$415M Sell
3,657,518
-103,592
-3% -$11.4M 2.08% 9
2019
Q3
$409M Sell
3,761,110
-105,463
-3% -$11M 2.17% 8
2019
Q2
$377M Sell
3,866,573
-44,775
-1% -$4.09M 2.01% 10
2019
Q1
$356M Buy
3,911,348
+25,556
+0.7% +$2.29M 1.96% 14
2018
Q4
$353M Sell
3,885,792
-820
-0% -$76.6K 2.07% 9
2018
Q3
$382M Sell
3,886,612
-132,023
-3% -$12.2M 1.91% 14
2018
Q2
$344M Sell
4,018,635
-208,705
-5% -$17.4M 1.77% 17
2018
Q1
$339M Buy
4,227,340
+161,270
+4% +$13.3M 1.74% 17
2017
Q4
$328M Buy
4,066,070
+624,370
+18% +$50M 1.65% 19
2017
Q3
$268M Buy
3,441,700
+762,008
+28% +$63.3M 1.41% 25
2017
Q2
$238M Buy
2,679,692
+81,830
+3% +$6.9M 1.28% 27
2017
Q1
$209M Sell
2,597,862
-17,540
-0.7% -$1.37M 1.17% 34
2016
Q4
$186M Buy
2,615,402
+229,489
+10% +$18M 1.08% 37
2016
Q3
$206M Sell
2,385,913
-84,392
-3% -$7.35M 1.27% 25
2016
Q2
$214M Sell
2,470,305
-44,958
-2% -$3.64M 1.35% 25
2016
Q1
$189M Sell
2,515,263
-920,934
-27% -$69.4M 1.2% 35
2015
Q4
$264M Sell
3,436,197
-30,267
-0.9% -$2.28M 1.75% 21
2015
Q3
$232M Sell
3,466,464
-84,064
-2% -$6.19M 1.6% 24
2015
Q2
$263M Sell
3,550,528
-16,174
-0.5% -$1.24M 1.75% 18
2015
Q1
$278M Sell
3,566,702
-111,686
-3% -$8.46M 1.93% 16
2014
Q4
$266M Sell
3,678,388
-25,403
-0.7% -$1.76M 1.9% 16
2014
Q3
$229M Sell
3,703,791
-901,839
-20% -$57.3M 1.77% 21
2014
Q2
$294M Sell
4,605,630
-743,588
-14% -$45.2M 2.31% 9
2014
Q1
$329M Buy
5,349,218
+76,248
+1% +$4.44M 2.82% 2
2013
Q4
$303M Sell
5,272,970
-40,615
-0.8% -$2.3M 2.76% 3
2013
Q3
$283M Sell
5,313,585
-43,725
-0.8% -$2.35M 2.85% 5
2013
Q2
$276M Buy
+5,357,310
New +$265M 2.97% 2

Other funds holding MDT

Diamond Hill Capital Management's MDT Position: Q2 2026 in Review

Diamond Hill Capital Management reduced its Medtronic (MDT) stake by 15% in Q2 2026, selling an estimated $24.2M and leaving 1,684,110 shares worth $132M. The position accounts for 1.05% of the portfolio, ranked #32.

Diamond Hill Capital Management first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $576M in Q3 2021. 2,123 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Diamond Hill Capital Management held 1,684,110 shares of Medtronic worth $132M as of Q2 2026.
  • Diamond Hill Capital Management sold 299,750 Medtronic shares in Q2 2026, an estimated $24.2M.
  • Medtronic made up 1.05% of Diamond Hill Capital Management's portfolio in Q2 2026, its #32 holding.
  • Diamond Hill Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Diamond Hill Capital Management's Medtronic position peaked at $576M in Q3 2021.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Diamond Hill Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.